blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0742830

EP0742830 - FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.05.2002
Database last updated on 31.08.2024
Most recent event   Tooltip04.01.2008Lapse of the patent in a contracting state
New state(s): CH, IT, LI		published on 06.02.2008  [2008/06]
Applicant(s)For all designated states
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services
Office of Technology Transfer, 6011 Executive Blvd., Suite 325 Rockville
Maryland 20852 / US
[N/P]
Former [1996/51]For all designated states
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services
Office of Technology Transfert, 6011 Executive Blvd., Suite 325
Rockville, Maryland 20852 / US
Former [1996/47]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT
Bethesda, MD 20892-9902 / US
Inventor(s)01 / LAROCHELLE, William, J.
18812 Purple Martin Lane
Gaithersburg, MD 20879 / US
02 / AARONSON, Stuart, A.
1006 Harriman Street
Great Falls, VA 22066 / US
03 / DIRSCH, Olaf
5327 McKinley Street
Bethesda, MD 20814 / US
[1996/47]
Representative(s)Warcoin, Jacques, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1996/47]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
75116 Paris / FR
Application number, filing date95908666.101.02.1995
[1996/47]
WO1995US00974
Priority number, dateUS1994018955201.02.1994         Original published format: US 189552
[1996/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9521258
Date:10.08.1995
Language:EN
[1995/34]
Type: A1 Application with search report 
No.:EP0742830
Date:20.11.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 10.08.1995 takes the place of the publication of the European patent application.
[1996/47]
Type: B1 Patent specification 
No.:EP0742830
Date:18.07.2001
Language:EN
[2001/29]
Search report(s)International search report - published on:EP10.08.1995
ClassificationIPC:C12N15/62, C07K19/00, C07K16/00, C07K14/71, G01N33/566
[1996/47]
CPC:
C07K14/71 (EP,US); C07K16/00 (EP,US); A61K38/00 (EP,US);
C07K2319/02 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/47]
TitleGerman:FUSIONIERTE PROTEINE DIE ANTIKÖRPER-TEILE UND NICHT-ANTIKÖRPER-TEILE ENTHALTEN[1996/47]
English:FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS[1996/47]
French:PROTEINES DE FUSION COMPRENANT DES PARTIES ANTICORPS ET NON ANTICORPS[2001/09]
Former [1996/47]PROTEINES DE FUSION COMPRENANT DES PARTIES ANTICORPALES ET NON ANTICORPALES
Entry into regional phase26.08.1996National basic fee paid 
26.08.1996Designation fee(s) paid 
14.10.1996Examination fee paid 
Examination procedure30.08.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
14.10.1996Examination requested  [1996/50]
09.11.1998Despatch of a communication from the examining division (Time limit: M04)
15.03.1999Reply to a communication from the examining division
08.09.1999Despatch of a communication from the examining division (Time limit: M06)
21.02.2000Reply to a communication from the examining division
29.08.2000Despatch of communication of intention to grant (Approval: No)
29.12.2000Despatch of communication of intention to grant (Approval: later approval)
15.01.2001Communication of intention to grant the patent
26.03.2001Fee for grant paid
26.03.2001Fee for publishing/printing paid
Opposition(s)19.04.2002No opposition filed within time limit [2002/28]
Fees paidRenewal fee
26.02.1997Renewal fee patent year 03
26.01.1998Renewal fee patent year 04
25.01.1999Renewal fee patent year 05
21.01.2000Renewal fee patent year 06
22.01.2001Renewal fee patent year 07
Penalty fee
Penalty fee Rule 85b EPC 1973
09.10.1996M01   Fee paid on   14.10.1996
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.07.2001
BE18.07.2001
CH18.07.2001
IT18.07.2001
LI18.07.2001
NL18.07.2001
DK18.10.2001
PT18.10.2001
SE18.10.2001
GR19.10.2001
ES31.01.2002
IE01.02.2002
LU01.02.2002
[2008/06]
Former [2004/51]AT18.07.2001
BE18.07.2001
NL18.07.2001
DK18.10.2001
PT18.10.2001
SE18.10.2001
GR19.10.2001
ES31.01.2002
IE01.02.2002
LU01.02.2002
Former [2004/39]AT18.07.2001
BE18.07.2001
NL18.07.2001
DK18.10.2001
PT18.10.2001
SE18.10.2001
ES31.01.2002
IE01.02.2002
LU01.02.2002
Former [2004/04]AT18.07.2001
BE18.07.2001
NL18.07.2001
DK18.10.2001
PT18.10.2001
SE18.10.2001
ES31.01.2002
IE01.02.2002
Former [2003/45]AT18.07.2001
BE18.07.2001
NL18.07.2001
DK18.10.2001
PT18.10.2001
SE18.10.2001
IE01.02.2002
Former [2003/17]AT18.07.2001
BE18.07.2001
NL18.07.2001
PT18.10.2001
SE18.10.2001
IE01.02.2002
Former [2003/08]AT18.07.2001
BE18.07.2001
NL18.07.2001
PT18.10.2001
SE18.10.2001
Former [2002/29]AT18.07.2001
BE18.07.2001
PT18.10.2001
SE18.10.2001
Former [2002/26]AT18.07.2001
PT18.10.2001
SE18.10.2001
Former [2002/15]AT18.07.2001
SE18.10.2001
Former [2002/05]SE18.10.2001
Cited inInternational search[Y]EP0325224  (ZYMOGENETICS INC [US]) [Y] 1-26* example 12D *
 [Y]  - MARK ET AL., "Expression and characterization of Hepatocyte Growth Factor Receptor-IgG fusion proteins", JOURNAL OF BIOLOGICAL CHEMISTRY (MICROFILMS), MD US, (19921225), vol. 267, no. 36, pages 26166 - 26171 [Y] 1-26 * figure 1 *
 [Y]  - LYMAN ET AL., "Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferaive factor for primitive hematopoietic cells", CELL, NA US, (19931217), vol. 75, no. 6, pages 1157 - 1167 [Y] 1-26 * page 1164, column L, paragraph 2 *
 [PX]  - CHEON ET AL., "High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, WASHINGTON US, (19940201), vol. 91, no. 3, pages 989 - 993 [PX] 1-26 * the whole document *
 [PX]  - HEIDARAN ET AL., "betaPDGFR-IgG chimera demonstrates that human betaPDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding", FASEB JOURNAL FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD US, vol. 9, no. 1, pages 140 - 145 [PX] 1-26 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.